Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritis [1]

Annals of the Rheumatic Diseases

Volumn 67, Issue 1, 2008, Pages 134-135

  Radstake, T R D J ^a   Fransen, J ^a   Van Riel, P L C M ^a   Toonen, E ^a   Coenen, M ^a   Donn, R ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; RHEUMATOID FACTOR;

ADULT; ALLELE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ACTIVITY SCORE; DISEASE ASSOCIATION; DISEASE SEVERITY; EMBOLISM; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; LETTER; MAJOR CLINICAL STUDY; MALE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RATING SCALE; RHEUMATOID ARTHRITIS; RISK FACTOR;

ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 37749049216     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.079111     Document Type: Letter

References (7)

1. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson c, O'Fallon WM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years Arthritis Rheum 2003;48:54-8.
2. Mikuls TR. Co-morbidity in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2003;17:729-52.
3. Maradit-Kremers H, Crowson CS, Nicola PJ, Rallman KV, Roger VL, Jacobsen SJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402-11.
4. Radstake TR, Sweep FC, Welsing P, Franke R, Vermeulen SH, Geurts-Moespot A, et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005;52:3020-9.
5. Donn R, Alourfi Z, Zeggini E, Lamb R, Jury F, Lunt M, et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 2004;50:1604-10.
6. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
7. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van De Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis [see comments]. Arthritis Rheum 1995;38:44-8.